Exane Derivatives’s QuidelOrtho QDEL Stock Holding History

Exane Derivatives’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$680	Sell	7 -292	-98%	-$29.8K	﹤0.01%	542
2022 Q1	$33.6K	Buy	299 +293	+4,883%	+$31.2K	0.01%	612
2021 Q4	$810	Hold	6	–	–	﹤0.01%	727
2021 Q3	$847	Hold	6	–	–	﹤0.01%	882
2021 Q2	$707	Hold	6	–	–	﹤0.01%	911
2021 Q1	$768	Sell	6 -996	-99%	-$184K	﹤0.01%	755
2020 Q4	$180K	Buy	+1,002	New	+$223K	0.05%	322

Other funds holding QDEL

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Exane Derivatives's QDEL Position: Q2 2022 in Review

Exane Derivatives reduced its QuidelOrtho (QDEL) stake by 98% in Q2 2022, selling an estimated $29.8K and leaving 7 shares worth $680. The position accounts for ﹤0.01% of the portfolio, ranked #542.

Exane Derivatives first reported a position in QDEL in Q4 2020 and has held it in 7 quarters since. The position peaked at $180K in Q4 2020. 347 funds tracked by Wall St. Rank hold QDEL as of Q2 2022.

Exane Derivatives held 7 shares of QuidelOrtho worth $680 as of Q2 2022.
Exane Derivatives sold 292 QuidelOrtho shares in Q2 2022, an estimated $29.8K.
QuidelOrtho made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #542 holding.
Exane Derivatives first reported a position in QuidelOrtho in Q4 2020 and has held it in 7 quarters since.
Exane Derivatives's QuidelOrtho position peaked at $180K in Q4 2020.
347 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.